Pfizer announced today a voluntary recall of a single lot of Lipitor (atorvastatin) tablets. The recall affects lot number R12345, distributed nationwide. This action comes after routine testing revealed a potential contamination with a non-harmful, but aesthetically displeasing, substance.

The company is working with wholesalers, distributors, and retailers to remove the affected lot from the market. Pfizer emphasizes that this recall is limited to the specified lot number and that other Lipitor products remain safe for consumption. Patients currently taking Lipitor tablets from lot number R12345 should contact their physician or pharmacist for guidance.

Pfizer is committed to patient safety and is taking this measure as a precautionary step. Consumers with questions can contact Pfizer’s customer service line at 1-800-Pfizer.